Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Cepheid s US Army Contract Boosted By $3.4 Million

NEW YORK, May 9-Cepheid said today that its contract with the U.S. Army's infectious disease research division has been extended for $3.4 million over the next two years.


Cepheid originally signed a $1.8 million contract in 2000 with the U.S. Army Medical Research Institute of Infectious Disease to design and build a portable biological warfare agent detection system. The company delivered a prototype at the close of 2001.


With this contract extension, Cepheid will expand the system for viral detection and sepsis detection. The company will also create an assay that can distinguish virulent and non-virulent varieties of anthrax.


Cepheid is based in Sunnyvale, Calif., and is publicly owned.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.